Search Results - Saconni, S.

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    638P Interleukin-6 as a biomarker for disease activity, progression and muscle composition in facioscapulohumeral dystrophy: insights from longitudinal studies

    638P Interleukin-6 as a biomarker for disease activity, progression and muscle composition in facioscapulohumeral dystrophy: insights from longitudinal studies by Saconni, S., Pini, J., Martinuzzi, E., Puma, A., Villa, L., Cavali, M., Ezaru, A., Garcia, J., Glaichenhaus, N.

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    637P ReInForce: a bicentric, randomized, double blind, placebo-controlled pilot study to evaluate the efficacy and safety of satralizumab in FSHD1

    637P ReInForce: a bicentric, randomized, double blind, placebo-controlled pilot study to evaluate the efficacy and safety of satralizumab in FSHD1 by Pini, J., Aleman, A., Breiner, A., Cavalli, M., Puma, A., Villa, L., Gaki, E., McIver, T., Okumu, S., Sidiropoulos, P., Lochmüller, H., Saconni, S.

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: